Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06971861

Just ACT for Student Well-being

Most psychological conditions start developing during adolescent years. This makes adolescence an ideal and critical window for prevention efforts that help enhance stress management and mental health among the younger generations. This pilot study aims to develop a brief prevention program that focuses on youths' well-being and living as guided by their personal values.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acceptance and Commitment Therapy Behavior Personal Satisfaction Psychological Well-Being

Age range

10 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

New Life Psychiatric Rehabilitation Association

Hong Kong, 00000

Location status: Recruiting

Location contact

Head of Professional Services (Community Services)

CONTACT

[email protected]

+852-23192103

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age of 35 years or below
  • fluency in oral and written Chinese

Exclusion criteria

  • active or current history of psychosis, bipolar disorder, or personality disorder
  • active or current report of suicidal attempts
  • active or current suicidal ideations for more than half the days
  • any history of intellectual deficits

Treatment and study plan

Acceptance and Commitment Therapy

Behavioral

The current program is based on ACT and consists of four one-hour sessions covering the six core components of psychological flexibility. The four sessions respectively focus on Cognitive Defusion, Being Present and Acceptance, Self-as-Context and Values, and Committed Action. All sessions involve experiential learning activities and reflective discussions. Each participant also receives a workbook to facilitate post-session home practice.

Other names: ACT

Primary outcomes

  1. Attendance

    Time frame: At the end of treatment

    Attendance across four sessions in percentage

  2. Change in psychological flexibility as measured with the Multidimensional Psychological Flexibility Inventory

    Time frame: Before treatment, between the second and third session, within one week after treatment, and one month after treatment

    The Multidimensional Psychological Flexibility Inventory (MPFI; Rolffs et al., 2018) is the only validated measure that provides separate ratings on the six core processes of ACT (see Barrett et al., 2019). Items are rated on a 6-point Likert scale, from 1 - Never True to 6 - Always True, and averaged to obtain a score for each of the dimensions.

Secondary outcomes

  1. Treatment retention

    Time frame: At the end of treatment

    Percentage of participants staying in treatment through the end

  2. Change in well-being as measured with the Flourishing Scale

    Time frame: Before treatment, within a week after treatment, and one month after treatment

    The Flourishing Scale (FS) is an 8-item rating scale that measures sociopsychological prosperity, in terms of social relationships, purposeful or meaningful living, self-respect, and feeling of competence. Items are rated on a 7-point Likert scale, from 1 - Strong Disagreement to 7 - Strong Agreement.

  3. Change in depressive symptoms as measured with Patient Health Questionnaire (PHQ-9)

    Time frame: Before treatment, within a week after treatment, and one month after treatment

    The nine-item Patient Health Questionnaire (PHQ-9; Kroenke & Spitzer, 2002) is a gold-standard measure of depressive symptoms an individual experienced in the prior two-week period. Items are rated on a 4-point Likert scale, from 0 - Not at All to 3 - Nearly Every Day. Total score on the PHQ-9 ranges from 0 to 27, with higher scores indicating more severe impact of depressive symptoms on an individual's life.

  4. Change in anxiety symptoms as measured with the Generalized Anxiety Disorder (GAD-7)

    Time frame: Before treatment, within a week after treatment, and one month after treatment

    The seven-item Generalized Anxiety Disorder (GAD-7; Spitzer et al., 2006) is a gold-standard measure of anxiety symptoms an individual experienced in the prior two-week period. Items are rated on a 4-point Likert scale, from 0 - Not at All to 3 - Nearly Every Day. Total score on the GAD-7 ranges from 0 to 21, with higher scores indicating more severe impact of anxiety symptoms on an individual's life.

  5. Treatment satisfaction

    Time frame: Within a week after treatment

    Participants are invited to rate on a 5-point Likert scale, from 1 - Strongly Disagree to 5 - Strongly Agree, designed specifically to assess their level of satisfaction with the intervention received in the current study. They are also asked in an open-ended way to provide qualitative feedback on the program, including their overall or any specific experience with the program not otherwise captured by the pre-set prompting questions.

Study contacts

Contact information is provided by the study sponsor or research team.

Director

CONTACT

[email protected]

+852-39175889

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Collaborators

  • New Life Psychiatric Rehabilitation Association

Registry information

Official study title

Just ACT: School-Based Program Using Acceptance and Commitment Therapy (ACT) to Promote Student Well-being

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
May 14, 2025
Registry last updated
Aug 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.